These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23305392)

  • 21. The use of mRNA display to select high-affinity protein-binding peptides.
    Wilson DS; Keefe AD; Szostak JW
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3750-5. PubMed ID: 11274392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of mRNA-display-based selections using synthetic peptide and natural protein libraries.
    Huang BC; Liu R
    Biochemistry; 2007 Sep; 46(35):10102-12. PubMed ID: 17685586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The production of the first functional antibody mimetic in higher plants: the chloroplast makes the DARPin G3 for HER2 imaging in oncology.
    Ehsasatvatan M; Kohnehrouz BB; Gholizadeh A; Ofoghi H; Shanehbandi D
    Biol Res; 2022 Oct; 55(1):32. PubMed ID: 36274167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, Characterization, and Selective Delivery of DARPin-Gold Nanoparticle Conjugates to Cancer Cells.
    Deyev S; Proshkina G; Ryabova A; Tavanti F; Menziani MC; Eidelshtein G; Avishai G; Kotlyar A
    Bioconjug Chem; 2017 Oct; 28(10):2569-2574. PubMed ID: 28806065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting.
    Dreier B; Mikheeva G; Belousova N; Parizek P; Boczek E; Jelesarov I; Forrer P; Plückthun A; Krasnykh V
    J Mol Biol; 2011 Jan; 405(2):410-26. PubMed ID: 21056576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PURE mRNA display and cDNA display provide rapid detection of core epitope motif via high-throughput sequencing.
    Reyes SG; Kuruma Y; Fujimi M; Yamazaki M; Eto S; Nishikawa S; Tamaki S; Kobayashi A; Mizuuchi R; Rothschild L; Ditzler M; Fujishima K
    Biotechnol Bioeng; 2021 Apr; 118(4):1736-1749. PubMed ID: 33501662
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Newton MS; Cabezas-Perusse Y; Tong CL; Seelig B
    ACS Synth Biol; 2020 Feb; 9(2):181-190. PubMed ID: 31891492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pure translation display.
    Forster AC; Cornish VW; Blacklow SC
    Anal Biochem; 2004 Oct; 333(2):358-64. PubMed ID: 15450813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure and function of a DARPin neutralizing inhibitor of lactococcal phage TP901-1: comparison of DARPin and camelid VHH binding mode.
    Veesler D; Dreier B; Blangy S; Lichière J; Tremblay D; Moineau S; Spinelli S; Tegoni M; Plückthun A; Campanacci V; Cambillau C
    J Biol Chem; 2009 Oct; 284(44):30718-26. PubMed ID: 19740746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four-base codon mediated mRNA display to construct peptide libraries that contain multiple nonnatural amino acids.
    Muranaka N; Hohsaka T; Sisido M
    Nucleic Acids Res; 2006 Jan; 34(1):e7. PubMed ID: 16397292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective staining and eradication of cancer cells by protein-carrying DARPin-functionalized liposomes.
    Deyev S; Proshkina G; Baryshnikova O; Ryabova A; Avishai G; Katrivas L; Giannini C; Levi-Kalisman Y; Kotlyar A
    Eur J Pharm Biopharm; 2018 Sep; 130():296-305. PubMed ID: 29959035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly specific hybrid protein DARPin-mCherry for fluorescent visualization of cells overexpressing tumor marker HER2/neu.
    Mironova KE; Chernykh ON; Ryabova AV; Stremovskiy OA; Proshkina GM; Deyev SM
    Biochemistry (Mosc); 2014 Dec; 79(12):1391-6. PubMed ID: 25716734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro selection of unnatural cyclic peptide libraries via mRNA display.
    Ma Z; Hartman MC
    Methods Mol Biol; 2012; 805():367-90. PubMed ID: 22094817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DARPin_9-29-Targeted Mini Gold Nanorods Specifically Eliminate HER2-Overexpressing Cancer Cells.
    Proshkina G; Deyev S; Ryabova A; Tavanti F; Menziani MC; Cohen R; Katrivas L; Kotlyar A
    ACS Appl Mater Interfaces; 2019 Sep; 11(38):34645-34651. PubMed ID: 31448887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biogenesis of the cyanellae of Cyanophora paradoxa. III. In vitro synthesis of cyanellar polypeptides using separated cytoplasmic and cyanellar RNA.
    Burnap RL; Trench RK
    Proc R Soc Lond B Biol Sci; 1989 Oct; 238(1290):89-102. PubMed ID: 2574471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries.
    Amstutz P; Koch H; Binz HK; Deuber SA; Plückthun A
    Protein Eng Des Sel; 2006 May; 19(5):219-29. PubMed ID: 16551653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of phage display technique for improved screening of high-affinity binding peptides.
    Yun S; Lee S; Park JP; Choo J; Lee EK
    J Biotechnol; 2019 Jan; 289():88-92. PubMed ID: 30496775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designed Ankyrin Repeat Proteins as Her2 Targeting Domains in Chimeric Antigen Receptor-Engineered T Cells.
    Siegler E; Li S; Kim YJ; Wang P
    Hum Gene Ther; 2017 Sep; 28(9):726-736. PubMed ID: 28796529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of the candidate inhibitory peptides of subtilisin by in vitro RNA display technique.
    Wang H; Song P; Li X; Wang Y; Gui S; Liu Y; Lu F
    Int J Biol Macromol; 2020 Nov; 163():1162-1167. PubMed ID: 32673721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mRNA display: diversity matters during in vitro selection.
    Gold L
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4825-6. PubMed ID: 11320229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.